Revance Therapeutics to Release First Quarter 2018 Financial Results on Tuesday, May 8, 2018
-Conference Call Scheduled for
Individuals interested in listening to the conference call may do so by dialing (855) 453-3827 for domestic callers, or (484) 756-4301 for international callers and reference conference ID: 4580549; or from the webcast link in the investor relations section of the company's website at: www.revance.com.
A replay of the call will be available beginning
"Revance Therapeutics" and the Revance logo are registered trademarks of
Nadine Tosk, 504-453-8344
News Provided by Acquire Media